Evidence map›Paper›PMID 31490656›Full record

ArticleACS chemical biology2019

Membrane Disruption by Very Long Chain Fatty Acids during Necroptosis.

Laura R Parisi, Shahin Sowlati-Hashjin, Ilyas A Berhane, Samuel L Galster, Kevin A Carter, Jonathan F Lovell, Sherry R Chemler, Mikko Karttunen, G Ekin Atilla-Gokcumen

Open access · greenAbstract read
In one paragraph

Article in ACS chemical biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Mixed Lineage Kinase Domain-Like Protein (MLKL): From Mechanisms to Therapeutic Opportunities.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Laura R ParisiDepartment of Chemistry , University at Buffalo, The State University of New York , Buffalo , New York 14260 , United States.ORCID 0000-0003-4868-1426
Shahin Sowlati-HashjinDepartment of Chemistry , The University of Western Ontario , 1151 Richmond Street , London , Ontario N6A 5B7 , Canada.ORCID 0000-0001-6968-1535
Ilyas A BerhaneDepartment of Chemistry , University at Buffalo, The State University of New York , Buffalo , New York 14260 , United States.
Samuel L GalsterDepartment of Chemistry , University at Buffalo, The State University of New York , Buffalo , New York 14260 , United States.
Kevin A CarterDepartment of Biomedical Engineering , University at Buffalo, The State University of New York , Buffalo , New York 14260 , United States.
Jonathan F LovellDepartment of Biomedical Engineering , University at Buffalo, The State University of New York , Buffalo , New York 14260 , United States.ORCID 0000-0002-9052-884X
Sherry R ChemlerDepartment of Chemistry , University at Buffalo, The State University of New York , Buffalo , New York 14260 , United States.ORCID 0000-0001-6702-5032
Mikko KarttunenDepartment of Chemistry , The University of Western Ontario , 1151 Richmond Street , London , Ontario N6A 5B7 , Canada.ORCID 0000-0002-8626-3033
G Ekin Atilla-GokcumenDepartment of Chemistry , University at Buffalo, The State University of New York , Buffalo , New York 14260 , United States.ORCID 0000-0002-7132-3873
University at Buffalo, State University of New York · USWestern University · CA

Funding

New Methods for Nitrogen Heterocycle SynthesisR01GM078383 · NIGMS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI CHEMLER, SHERRY R · 2006 to 2023
$5.6M
Light-Triggered Drug Release in Primed Pancreatic TumorsR01EB017270 · NIBIB · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI LOVELL, JONATHAN F · 2013 to 2021
$3.5M
Targeting Tumors with Resealable Nanovesicles Permeabilized by NIR LightDP5OD017898 · OD · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI LOVELL, JONATHAN F · 2013 to 2017
$1.9M
NIBIB NIH HHS R01 EB017270NIGMS NIH HHS R01 GM078383NIH HHS DP5 OD017898
6 · The paper itself

Abstract

Necroptosis is a form of regulated cell death which results in loss of plasma membrane integrity, release of intracellular contents, and an associated inflammatory response. We previously found that saturated very long chain fatty acids (VLCFAs), which contain ≥20 carbons, accumulate during necroptosis. Here, we show that genetic knockdown of Fatty Acid (FA) Elongase 7 (ELOVL7) reduces accumulation of specific very long chain FAs during necroptosis, resulting in reduced necroptotic cell death and membrane permeabilization. Conversely, increasing the expression of ELOVL7 increases very long chain fatty acids and membrane permeabilization.

Indexed as

AcylationCell MembraneFatty Acid ElongasesFatty AcidsGene Knockdown TechniquesHT29 CellsHumansLipid BilayersLiposomesMembrane ProteinsMolecular StructureNecroptosisELOVL7 protein, humanFatty Acid ElongasesFatty AcidsLipid BilayersLiposomesMembrane Proteins

Identifiers

PMID31490656
PMCPMC6800604
OpenAlexW2972001191

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.